Last reviewed · How we verify
NCT05546138: NeuroPredict
Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy
trial testing Skin biopsies with quantification of intra-epidermal nerve fibre density in Neuropathy, Diabetic in 200 participants. Currently enrolling.
31 December 2029
Quick facts
| Lead sponsor | Aalborg University Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 1 October 2023 |
| Primary completion | 31 December 2029 |
| Estimated completion | 31 December 2029 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Skin biopsies with quantification of intra-epidermal nerve fibre density
- Perception Threshold Tracking
- Thermal perception thresholds
- Corneal confocal Microscopy
- MRI — full drug profile →
- Nerve conduction studies
- Composite scores and questionnaires
Conditions studied
- Neuropathy, Diabetic — all drugs for Neuropathy, Diabetic →
- Small Nerve Fiber Neuropathy — all drugs for Small Nerve Fiber Neuropathy →
- Type 1 Diabetes — all drugs for Type 1 Diabetes →
Sponsor
Aalborg University Hospital
Who can join
Adults 18 to 60, any sex, with Neuropathy, Diabetic or Small Nerve Fiber Neuropathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Predicting early onset neuropathy in people with type 1 diabetes
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05546138
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Neuropathy, Diabetic
Currently open trials in the same condition.
- NCT06471517 — Neuroprosthetic Device for Improving Issues Caused by Diabetic Neuropathy With Specifically Designed Neural Stimulation · NA · recruiting
- NCT06376240 — The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes · NA · active not recruiting
Other Aalborg University Hospital trials
Trials by the same sponsor.
- NCT06960005 — ThyMoves: Screening and Exercise to Improve Muscle, Enhance Quality of Life, and Reduce Fall Risk in Thyroid Disease · NA · enrolling by invitation
- NCT06745544 — Impact of Screening and Multicomponent Exercise on Fall Rates, Fractures, and Cardiovascular Health in Diabetes · NA · recruiting
- NCT07185958 — Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy · not yet recruiting
- NCT07165574 — Prevalence of Anticholinergics in Geriatric Patients With Acute Functional Deterioration · not yet recruiting
- NCT07173413 — Assessing the Quality of Telephone Follow-Up After Spine Surgery · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05546138 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aalborg University Hospital
- Last refreshed: 28 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05546138.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing